Listen to a soundcast of the 8/10/2022 and 8/11/2022 FDA approvals of Tabrecta (capmatinib) for metastatic non-small cell lung cancer, ...

YouTube-U.S. Food and Drug Administration

Now, a new FDA approved therapy called capmatinib, is the first therapy available for a group of patients previously ineligible for targeted

YouTube-UCLA Jonsson Comprehensive Cancer Center

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib in Resectable NSCLC With MET Exon 14 Skipping Mutation or High MET ...

VuMedi

... capmatinib's MoA. TABRECTA™ is a kinase inhibitor, operating by blocking a key enzyme that results in helping to stop the tumor cells from ...

YouTube-Random42 Scientific Communication

... capmatinib About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact ...

LabTube

Matthew Krebs, MBChB, MRCP, PhD, The Christie NHS Foundation Trust, Manchester, UK, discusses updated results from CHRYSALIS (NCT02609776), ...

YouTube-VJOncology

Capmatinib, kutu adı Tabrecta olan ve MET genetik değişimine yönelik bir akıllı kanser ilacıdır. 6 Mayıs 2020'de MET pozitif ileri evre ...

YouTube-Prof. Dr. Mustafa Özdoğan

... capmatinib and tepotinib used to treat the MET exon 14 skipping mutation. Cancer can become resistant to targeted therapy treatments, so it ...

YouTube-You and Lung Cancer

C'è una novità importante per la cura di alcuni pazienti con tumore del polmone non a piccole cellule. L'Agenzia italiana del farmaco (Aifa) ...

YouTube-PharmaStarTV

What is Capmatinib? Efficacy and Safety of a Targeted Cancer Drug Used in a MET Gene Alteration. Prof. Dr. Mustafa Özdoğan•154 views · 6:13.

YouTube-American Lung Association

What is Capmatinib? Efficacy and Safety of a Targeted Cancer Drug Used in a MET Gene Alteration. Prof. Dr. Mustafa Özdoğan•154 views · 4:20.

YouTube-Prof. Dr. Mustafa Özdoğan

FDA D.I.S.C.O. Burst Edition: FDA approvals of Tabrecta (capmatinib) for metastatic non-small cel... U.S. Food and Drug Administration · 3:01 · FDA D.I.S.C.O. ...

YouTube-U.S. Food and Drug Administration

Xiuning Le, MD PhD, The University of Texas MD Anderson Cancer Centre, Houston, TX, reports the notable outcomes of the Phase II VISION ...

YouTube-VJOncology

FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•943 views · 4:49. Go to channel · Common Skin Side ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

0:46. Go to channel · FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•950 views · 2:50. Go to channel ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

Go to channel · FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•952 views · 3:19. Go to channel ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

0:46 · Go to channel. FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•949 views · 22:24 · Go to ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

0:46 · Go to channel · FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•952 views · 17:32 · Go to ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

Go to channel · FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•950 views · 2:17 · Go to channel ...

YouTube-UCLA Jonsson Comprehensive Cancer Center

0:46. Go to channel. FDA Approves Capmatinib for Advanced Lung Cancer. UCLA Jonsson Comprehensive Cancer Center•950 views · 2:05 · Go to channel ...

YouTube-UCLA Jonsson Comprehensive Cancer Center